Wednesday, June 10, 2026

pharma Β· Renal Transplantation Β· Rheumatoid Arthritis (RA)

Astellas Pharma

Astellas Pharma clinical programs β€” 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP HQ
12,378 Employees
NMPA registrant Type
Company details
Status
Public
HQ
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP
Employees
12,378
Programs
20
Drugs
12
Patents
25
Intelligence Β· Clinical Programs

Astellas Pharma projects

3 ClinicalTrials.gov programs sponsored by Astellas Pharma.

Astellas Pharma has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ASP1941

    Astellas Pharma Inc

    Healthy

    phase 1 small molecule completed

    1 trial
  2. ESN364

    Astellas Pharma Inc

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  3. TRK-100STP (BERASUS LA)

    Astellas Pharma Inc

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Astellas Pharma have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.